US Patent Office Rejects Benitec's Latest Move to Uphold Core IP; Firm May Appeal | GenomeWeb

Benitec last week experienced another setback in its attempts to maintain its core US patent after the US Patent and Trademark Office opted not to accept the company's most recent response to the ongoing re-examination of the intellectual property.

According to Benitec, the patent office decided not to enter into the re-examination proceedings the company's proposed amendments to the patent, as well as related arguments and evidence. The expressed RNAi shop said it may appeal the decision, which it said the agency made based purely on procedural grounds.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

Sponsored by
HTG Molecular

This webinar will discuss potential clinical applications for miRNA signatures and a novel, extraction-free miRNA profiling technology for advancing biomarker discovery.